1. Home
  2. IPHA vs FET Comparison

IPHA vs FET Comparison

Compare IPHA & FET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • FET
  • Stock Information
  • Founded
  • IPHA 1999
  • FET 2005
  • Country
  • IPHA France
  • FET United States
  • Employees
  • IPHA N/A
  • FET N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • FET Metal Fabrications
  • Sector
  • IPHA Health Care
  • FET Industrials
  • Exchange
  • IPHA Nasdaq
  • FET Nasdaq
  • Market Cap
  • IPHA 160.1M
  • FET 187.2M
  • IPO Year
  • IPHA 2019
  • FET 2012
  • Fundamental
  • Price
  • IPHA $1.83
  • FET $19.76
  • Analyst Decision
  • IPHA Strong Buy
  • FET
  • Analyst Count
  • IPHA 1
  • FET 0
  • Target Price
  • IPHA $11.00
  • FET N/A
  • AVG Volume (30 Days)
  • IPHA 10.0K
  • FET 64.9K
  • Earning Date
  • IPHA 03-27-2025
  • FET 07-31-2025
  • Dividend Yield
  • IPHA N/A
  • FET N/A
  • EPS Growth
  • IPHA N/A
  • FET N/A
  • EPS
  • IPHA N/A
  • FET N/A
  • Revenue
  • IPHA $20,831,349.00
  • FET $807,312,000.00
  • Revenue This Year
  • IPHA $209.83
  • FET N/A
  • Revenue Next Year
  • IPHA $83.15
  • FET $1.73
  • P/E Ratio
  • IPHA N/A
  • FET N/A
  • Revenue Growth
  • IPHA N/A
  • FET 7.31
  • 52 Week Low
  • IPHA $1.29
  • FET $12.78
  • 52 Week High
  • IPHA $3.51
  • FET $21.57
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 33.33
  • FET 74.24
  • Support Level
  • IPHA $1.82
  • FET $19.50
  • Resistance Level
  • IPHA $2.21
  • FET $20.66
  • Average True Range (ATR)
  • IPHA 0.07
  • FET 0.84
  • MACD
  • IPHA -0.03
  • FET 0.43
  • Stochastic Oscillator
  • IPHA 6.74
  • FET 88.42

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.

Share on Social Networks: